Open AccessMetabolic syndrome and role of ACE inhibitors in its management: focus on trandolapril
Author(s) -
В. И. Маколкин
Publication year - 2006
Publication title -
arterialʹnaâ gipertenziâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.126
H-Index - 5
eISSN - 2411-8524
pISSN - 1607-419X
DOI - 10.18705/1607-419x-2006-12-2-121-124
Subject(s) - trandolapril , metabolic syndrome , medicine , ace inhibitor , angiotensin converting enzyme , obesity , blood pressure
The review describes modern view in metabolic syndrome, diagnostic criteria and management. ACE inhibitors are shown to be indicated to such patients. Trandolapril due to its significant advantages - long duration of action, dual elimination and high tissue activity can be considered predominantly indicated to patients with metabolic syndrome.